Royalty Pharma plc Interest Coverage Ratio for the Trailing 12 Months (TTM) ending March 31, 2025: 6.61

Royalty Pharma plc Interest Coverage Ratio is 6.61 for the Trailing 12 Months (TTM) ending March 31, 2025, a 122.94% change year over year. Interest coverage ratio assesses earnings' ability to cover interest expenses; higher ratios signal lower risk.
  • Royalty Pharma plc Interest Coverage Ratio for the Trailing 12 Months (TTM) ending March 31, 2024 was 2.96, a 7.09% change year over year.
  • Royalty Pharma plc Interest Coverage Ratio for the Trailing 12 Months (TTM) ending March 31, 2023 was 2.77, a -63.82% change year over year.
  • Royalty Pharma plc Interest Coverage Ratio for the Trailing 12 Months (TTM) ending March 31, 2022 was 7.65, a -29.95% change year over year.
  • Royalty Pharma plc Interest Coverage Ratio for the Trailing 12 Months (TTM) ending March 31, 2021 was 10.92, a 9.04% change year over year.
Key Data
Date Interest Coverage Ratio Return on Capital Employed (ROCE) Return on Equity (ROE) Return on Assets (ROA)